SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Gilead
Gilead
Health
U.S. approves twice-a-year shot to prevent HIV but cuts to public health and foreign aid cloud its prospects
By
Lauran Neergaard
and
The Associated Press
June 19, 2025
Health
A twice-yearly shot of this drug could help end AIDS — ‘it’s unprecedented’
By
Maria Cheng
,
María Verza
and
The Associated Press
December 2, 2024
Conferences
Gilead’s remdesivir is now used to treat half of hospitalized COVID patients
By
Sy Mukherjee
April 28, 2021
Finance
AstraZeneca’s stock is soaring on COVID, but the pandemic has dented its growth
By
Jeremy Kahn
November 6, 2020
Newsletters
Gilead just got the first FDA coronavirus treatment approval, but there are still problems
By
Sy Mukherjee
October 22, 2020
Health
Gilead says remdesivir slashes coronavirus deaths. But it’s complicated
By
Sy Mukherjee
July 10, 2020
Newsletters
Coronavirus exposes the trouble of scientific unknowns
By
Sy Mukherjee
July 10, 2020
Health
COVID treatment remdesivir will cost $520 per vial. But it may not be how much you pay
By
Sy Mukherjee
June 29, 2020
Health
Gilead to charge thousands for coronavirus treatment drug that critics say should cost $1
By
Robert Langreth
and
Bloomberg
June 29, 2020
Health
Gilead’s next COVID-19 treatment advancement could keep patients out of hospitals
By
Sy Mukherjee
June 22, 2020
Health
Rumors swirl about an AstraZeneca and Gilead megadeal—but it doesn’t make sense
By
Sy Mukherjee
June 8, 2020
Magazine
Will COVID-19 change how Big Pharma does clinical trials?
By
Erika Fry
May 15, 2020
Health
Antibody testing will be key—once we understand what the results mean
By
Sy Mukherjee
May 12, 2020
Newsletters
Gilead’s moral (and financial) COVID-19 conundrum
By
Sy Mukherjee
May 7, 2020
Health
Remdesivir is the first coronavirus treatment. So why is Gilead’s stock plunging?
By
Sy Mukherjee
May 1, 2020
Most Popular
AI
'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the...
By
Jason Ma
Success
Be careful boomers, your Gen Z coworker may be recording you — 9-to-5s aren’t just about climbing the ladder, they’re...
By
Jessica Coacci
Success
Multimillion-dollar restaurant CEO used to splurge on Range Rovers and McLarens—but he’s reining it in now because...
By
Emma Burleigh